Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
07/2012
07/11/2012CN102574839A Novel compounds effective as xanthine oxidase inhibitors, method for preparing the same, and pharmaceutical composition containing the same
07/11/2012CN102574838A Pyrrole and [2,3-C] pyridine derivative using as P38 kinase inhibiting agents
07/11/2012CN102574836A Aminopyrazole derivative
07/11/2012CN102574835A Compounds useful for treating cancer
07/11/2012CN102574817A Aminoquinazoline compounds for combating invertebrate pests
07/11/2012CN102574813A Cyclic azine derivatives, processes for producing these, and organic electroluminescent element containing these as component
07/11/2012CN102574812A New benzimidazole derivatives and their use as fxr agonists
07/11/2012CN102574789A Pyrrolidinone carboxamide derivatives as chemerin-R ( CHEMR23 ) modulators
07/11/2012CN102574788A Indole derivatives as crac modulators
07/11/2012CN102574786A Dihydroorotate dehydrogenase inhibitors
07/11/2012CN102574785A Tetra-substituted heteroaryl compounds and their use as MDM2 and/or MDM4 modulators
07/11/2012CN102573479A 3-[1-(3-haloalkyl)-triazolyl]-phenyl-sulfide derivatives for use as acaricides and insecticides
07/11/2012CN102573478A 1- (pyrid-3-yl) -pyrazole and 1- (pyrimid-5-yl) -pyrazole as pesticide
07/11/2012CN102558158A Hairpin polyamide modified by or free of beta-hydroxyl-gamma-amino acid and preparation method and application
07/11/2012CN102558157A Ethoxyl-triazole compound or amonoethyl-triazole compound and preparation method and application thereof
07/11/2012CN102558156A Preparation method of 5-losartan carbonate
07/11/2012CN102558155A 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
07/11/2012CN102558075A Substituted piperazines as CB1 antagonists
07/11/2012CN102558074A Piperazine amide compound containing pyridazine substituent group
07/11/2012CN102558058A 1-aryl-3-substituent-5-substituted amino-4-pyrazole formamide compound and application thereof
07/11/2012CN102558023A Organic light-emitting device
07/11/2012CN102557982A Certain chemical entities, compositions, and methods
07/11/2012CN101885698B Pyrrolyl acrylamide compound and application thereof to synthesis of sunitinib
07/11/2012CN101353344B Pyrazolyl-substituted heterocycles and their use as phytosanitary products
07/10/2012US8217171 Antiviral agents
07/10/2012US8217168 Azabicyclo [3. 1. 0] hexyl derivatives as modulators of dopamine D3 receptors
07/10/2012US8217067 Antiinflammatory agents, antidepressants, analgesics, purinergic receptor antagonists; neurodegenerative diseases, spinal cord injuries; 1-(2,3-dichlorophenyl)-N-[(2-methylphenyl)methyl]-1H-tetraazol-5-amine
07/10/2012US8217048 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
07/10/2012US8217044 Spiroindolinone pyrrolidines
07/10/2012CA2547057C Malononitrile compound and use thereof
07/10/2012CA2545942C Aryl imidazoles and their use as anti-cancer agents
07/10/2012CA2526430C Indazole, benzisoxazole, and benzisothiazole kinase inhibitors
07/10/2012CA2520893C Process for the preparation of 1-n-(phenyl)-2-n-(phenyl)pyrrolidine-1,2-dicarboxamide derivatives and 1-(phenylcarbamoyl)pyrrolidine-2-carboxylic acid derivatives as intermediates
07/10/2012CA2513463C Gyrase inhibitors and uses thereof
07/10/2012CA2507381C Process for preparing quinazoline rho-kinase inhibitors and intermediates thereof
07/10/2012CA2481369C Inhibitors of serine proteases, particularly hepatitis c virus ns3 - ns4 protease
07/05/2012WO2012092409A2 Macrocyclic hepatitis c serine protease inhibitors
07/05/2012WO2012091279A1 Compound for an organic optoelectronic device, an organic light-emitting element comprising the same, and a display device comprising the organic light-emitting element
07/05/2012WO2012091026A1 1,3,5-triazine compound, method for preparing same, and organic electroluminescent element comprising same
07/05/2012WO2012089969A1 3,6-functionalized 1,2,4,5-tetrazines, method for preparation, compositions comprising same and use in detecting organic pollutants
07/05/2012WO2012089633A1 Novel pyrimidine derivatives, preparation thereof, and pharmaceutical use thereof as akt(pkb) phosphorylation inhibitors
07/05/2012WO2012089106A1 Aromatic alkyne derivative as protein kinase inhibitor and medical use thereof
07/05/2012WO2012064744A3 N- sulfonylated tetrahydroquinolines and related bicyclic compounds inhibition of rory activity and the treatment of diseases
07/05/2012US20120172593 Meta-stable state nitrogen-containing polymer
07/05/2012US20120172591 Inhibitors of human phosphatidylinositol 3-kinase delta
07/05/2012US20120172582 Labelling Strategies for the Sensitive Detection of Analytes
07/05/2012US20120172408 Active ingredient comprising indocyanine green and/or infracyanine green
07/05/2012US20120172385 Ortho substituted pyrimidine compounds as jak inhibitors
07/05/2012US20120172378 Novel compounds
07/05/2012US20120172368 Bis-Benzimidazole Derivatives
07/05/2012US20120172364 Rate-controlled particles
07/05/2012US20120172361 Triazine derivatives and their therapeutical applications
07/05/2012US20120172352 Pyrazoline dione derivatives as nadph oxidase inhibitors
07/05/2012US20120172337 Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses
07/05/2012US20120172290 Anti-Viral Compounds
07/05/2012US20120172217 Pesticidal compositions
07/05/2012US20120171665 Fluorescent markers and use thereof for labeling specific protein targets
07/05/2012US20120171129 Inhibition and Dispersion of Bacterial Biofilms with Benzimidazole Derivatives
07/05/2012US20120171125 Methods for Enhancing the Cognitive Function
07/05/2012US20120168741 Stilbene Derivatives, Light-Emitting Element, Display Device, and Electronic Device
07/05/2012US20120168731 Phenanthroazole compounds as hole transporting materials for electro luminescent devices
07/05/2012CA2822556A1 Macrocyclic hepatitis c serine protease inhibitors
07/04/2012EP2471787A1 New compounds
07/04/2012EP2471786A1 Aminopyrazole derivative
07/04/2012EP2471781A1 Benzyl aralkyl ether compounds, method for preparing same, intermediate compounds, use of said compounds, method for treatment and/or prevention, pharmaceutical composition and medicament containing same
07/04/2012EP2470535A2 Compositions, methods, and kits for determining an alkyl transferase
07/04/2012EP2470533A1 5,6-bicyclic heteroaryl-containing urea compounds as kinase inhibitors
07/04/2012EP2470530A1 Heterocyclic-substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof
07/04/2012EP2470529A1 A 1-(1h-1,2,4-triazol-1-yl)butan-2-ol derivative for pharmaceutical use, and the use of a 1-(1h-1,2,4-triazol-1-yl)butan-2-ol derivate with substantially undefined crystal shape for preparing said 1-(1h-1,2,4-triazol-1-yl)butan-2-ol derivative
07/04/2012EP2470528A1 Compounds and compositions as protein kinase inhibitors
07/04/2012EP2470527A1 Ether benzotriazole derivatives
07/04/2012EP2470526A1 Compounds and compositions as protein kinase inhibitors
07/04/2012EP2470512A1 Aromatase inhibitor
07/04/2012EP2470508A1 Cannabinoid receptor modulators
07/04/2012EP2470502A1 Tetra-substituted heteroaryl compounds and their use as mdm2 and/or mdm4 modulators
07/04/2012EP2470020A1 Benzodiazepinone compounds and methods of treatment using same
07/04/2012EP2062887B1 Aminopyridine derivative having aurora a-selective inhibitory activity
07/04/2012EP1863793B1 Hepatitis c virus inhibitors
07/04/2012EP1689233B1 Bicyclic inhibitors of mek
07/04/2012EP1487805B1 Pyrimidine derivatives
07/04/2012CN1962641B Metalloproteinase inhibitors
07/04/2012CN1953965B Novel cis-imidazolines
07/04/2012CN1832928B 5-membered heterocycle-based p38 kinase inhibitors
07/04/2012CN1809557B Compound
07/04/2012CN1449386B Nonpeptide substituted spirobenzoazepines as vasopressin antagonists
07/04/2012CN102548987A Fluoro-substituted compounds as kinase inhibitors and methods of use thereof
07/04/2012CN102548986A Aminopyrrolidinone derivatives and uses thereof
07/04/2012CN102548983A Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitor
07/04/2012CN102548975A Histone deacetylase inhibitors
07/04/2012CN102548970A Novel (6-oxo-1, 6-dihydro-pyrimidin-2-yl)-amide derivatives, preparation thereof, and pharmaceutical use thereof as AKT (PKB) phosphorylation inhibitors
07/04/2012CN102548963A Novel N-substituted-pyrrolidines as inhibitors of MDM2-p53 interactions
07/04/2012CN102548557A Compounds for the reduction of beta-amyloid production
07/04/2012CN102533252A Organic luminescent material and organic electroluminescent device
07/04/2012CN102532108A Process for preparing indol-5-oxy-quinazoline derivatives and intermediates
07/04/2012CN102532107A 4-substituted aniline-7-substituted alcoxylhomopiperazine-quinazoline derivatives, and preparation method and application thereof
07/04/2012CN101921265B Biphenylacylamine tetrazole compounds, synthetic method and application
07/04/2012CN101687860B Novel n- (8-heteroaryltetrahydronaphtalene-2yl) or n- (5- heteroarylchromane-3-yl) carboxamide derivatives for the treatment of pain
07/04/2012CN101087776B Organic compound, charge-transporting material, and organic electroluminescent element
07/03/2012US8212051 Process for the preparation of pure irbesartan
07/03/2012US8212048 Method of producing aromatic compound
1 ... 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 ... 626